Marketing of Unproven Stem Cell-Based Interventions: A Call to Action

Sci Transl Med. 2017 Jul 5;9(397):eaag0426. doi: 10.1126/scitranslmed.aag0426.

Abstract

Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Marketing*
  • Social Control, Formal
  • Stem Cell Transplantation / economics*
  • Stem Cell Transplantation / legislation & jurisprudence
  • Stem Cells / cytology*